首页> 外文期刊>British journal of nursing: BJN >Antipyretic drugs in patients with fever and infection: literature review.
【24h】

Antipyretic drugs in patients with fever and infection: literature review.

机译:发烧和感染患者的退热药物:文献综述。

获取原文
获取原文并翻译 | 示例
           

摘要

antipyretic drugs are routinely administered to febrile patients with infection in secondary care. However, the use of antipyretics to suppress fever during infection remains a controversial topic within the literature. It is argued that fever suppression may interfere with the body's natural defence mechanisms, and may worsen patient outcomes. a literature review was undertaken to determine whether the administration of antipyretic drugs to adult patients with infection and fever, in secondary care, improves or worsens patient outcomes. contrasting results were reported; two studies demonstrated improved patient outcomes following antipyretic administration, while several studies demonstrated increased mortality risk associated with antipyretics and/or demonstrated fever's benefits during infection. Results also demonstrated that health professionals continue to view fever as deleterious. the evidence does not currently support routine antipyretic administration. Considering patients' comorbidities and symptoms of their underlying illness will promote safe, evidence-based and appropriate administration of antipyretics.
机译:常规地施用于发热患者的反热药物在二次护理中感染。然而,在感染期间使用退化剂来抑制发烧仍然是文献内的有争议的话题。有人认为,发热抑制可能会干扰身体的自然防御机制,也可能会恶化患者的结果。进行了文献综述,以确定对次级护理,改善或恶化患者结果的感染和发烧的成年患者是否对成年患者进行治疗。报道了对比结果;两项研究证明了解尿液给药后改善了患者结果,而几项研究表明,在感染期间,与退析性和/或表明发烧的益处增加了增加的死亡风险。结果还表明,卫生专业人员继续认为发烧是有害的。证据目前尚未支持常规的解热给药。考虑到患者的潜在疾病的起理和症状将促进安全,证据和适当的退化术施用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号